Shaun Rosenthal

shaun rosenthal sanford heisler sharp
Shaun Rosenthal
Associate

(202) 499-5225

Email Shaun

View on LinkedIn

During law school, Shaun worked as a student-attorney in the Entrepreneurship Legal Clinic, and as a legal intern at SeniorLAW Center.

“I always intended to work for a firm that amplifies voices of the oppressed and attempts to make the world a better place. Working on matters ranging from employment discrimination to whistleblower actions, I feel like I am making a difference every day.”

Our commitment to securing justice and providing the best representation possible is reflected in a commitment to diversity within our own firm. At Sanford Heisler Sharp, LLP, we know better than to think the best attorneys look alike, sound alike, think alike, or live alike. What matters is talent, and we hire the best talent available.

As a result, our team more accurately mirrors America. Women, minority, and/or openly gay lawyers make up the majority of our staff. A passion for social justice unites our team - we all work to use the power of law to help create and enforce a more just society.

Shaun Rosenthal is an Associate in the Washington, DC office of Sanford Heisler Sharp, LLP, a national law firm with offices in the District of Columbia, New York, California, Tennessee, and Maryland. He received his J.D. from the University of Pennsylvania Law School and Honors Business Administration degree from the Ivey Business School of the University of Western Ontario.

Mr. Rosenthal first joined Sanford Heisler Sharp as a Summer Associate in 2017. During law school, he worked as a student-attorney in the Entrepreneurship Legal Clinic, and as a legal intern at SeniorLAW Center, where he represented older Pennsylvanians in their housing needs. He also interned at Lawyers for Human Rights in South Africa to help undocumented South Africans gain citizenship.

Education

  • J.D., University of Pennsylvania Law School, 2018
  • HBA, Ivey School of Business of the University of Western Ontario, 2015

Clinics

  • Entrepreneurship Legal Clinic

Bar Admissions

  • District of Columbia, 2020
  • New York, 2019

The Risk of Fraud as the Nation Responds to Coronavirus

The Department of Justice recently brought its first fraud case stemming from the coronavirus pandemic. The Assistant Attorney General Jody Hunt of the Justice Department’s Civil Division stated that “The Department of Justice will not tolerate criminal exploitation of this national emergency for personal gain” and that “We will use every resource at the government’s […]

Read More

S.E.C. Regulates Initial Coin Offerings

“Crypto crime”—that is, crime involving cryptocurrencies and other digital assets, including fraud and hacking—has cost investors approximately $4.3 billion in 2019 alone.[1] That number may rise as cryptocurrencies become more popular and accessible to the public. If cryptocurrencies and other digital assets are unregulated, companies and individuals can continue to prey on unsuspecting investors and […]

Read More

Promises and Protections of Whistleblower Actions

It has never been better to be a whistleblower. First, agencies within the United States are prioritizing tips from whistleblowers to determine their enforcement actions. Second, under certain whistleblower statutes, a whistleblower is entitled up to 30% of the proceeds from those enforcement actions. And third, there are strong protections in place to protect whistleblowers […]

Read More

The Underutilized False Claims Act and Other Whistleblower Statutes

The False Claims Act (“FCA”), 31 U.S.C. §§ 3729 et seq., is the Government’s primary tool to recover losses due to fraud and abuse by those seeking payment from the United States.  See S. Rep. No. 345, 99 Cong., 2nd Sess. at 2 (1986) reprinted in 1986 U.S.C.C.A.N 5266. The FCA is a whistleblower statute, […]

Read More

HHS Proposes Rule That Subjects Rebate System to Anti-Kickback Liability

The Department of Health and Human Services (HHS) announced a proposal to amend the Anti-Kickback Statute to expressly exclude from safe harbor protections rebates on prescription drugs paid by manufacturers to pharmacy benefit managers (PBMs), Part D plans, and Medicaid-managed care organizations.[1]  This proposal, if finalized, will alter the incentive structure for PBMs, benefiting consumers […]

Read More
Back to Top